List of Micardis drug patents
Micardis is owned by Boehringer Ingelheim.
Micardis contains Telmisartan.
Micardis has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Micardis are:
- US8003679
Micardis was authorised for market use on 10 November, 1998.
Micardis is available in tablet;oral dosage forms.
Micardis can be used as treatment or prevention of stroke.
The generics of Micardis are possible to be released after 06 October, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8003679 | BOEHRINGER INGELHEIM | Use of inhibitors of the renin-angiotensin system |
Oct, 2022
(3 months ago) | |
Drugs and Companies using TELMISARTAN ingredient
Market Authorisation Date: 10 November, 1998
Treatment: Treatment or prevention of stroke
Dosage: TABLET;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic